Raymond James Financial Services Advisors’s Synergy Pharmaceuticals, Inc Common Stock SGYP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-64,994
| Closed | -$110K | – | 2896 |
|
|
2018
Q3 | $110K | Sell |
64,994
-1,800
| -3% | -$3.05K | ﹤0.01% | 2643 |
|
|
2018
Q2 | $116K | Buy |
66,794
+18,505
| +38% | +$32.1K | ﹤0.01% | 2583 |
|
|
2018
Q1 | $88K | Buy |
48,289
+1,800
| +4% | +$3.28K | ﹤0.01% | 2389 |
|
|
2017
Q4 | $104K | Buy |
46,489
+6,500
| +16% | +$14.5K | ﹤0.01% | 2366 |
|
|
2017
Q3 | $116K | Buy |
39,989
+7,971
| +25% | +$23.1K | ﹤0.01% | 2370 |
|
|
2017
Q2 | $142K | Buy |
32,018
+3,900
| +14% | +$17.3K | ﹤0.01% | 2295 |
|
|
2017
Q1 | $131K | Sell |
28,118
-4,500
| -14% | -$21K | ﹤0.01% | 2221 |
|
|
2016
Q4 | $199K | Buy |
32,618
+12,780
| +64% | +$78K | ﹤0.01% | 2066 |
|
|
2016
Q3 | $109K | Hold |
19,838
| – | – | ﹤0.01% | 2134 |
|
|
2016
Q2 | $75K | Sell |
19,838
-10,691
| -35% | -$40.4K | ﹤0.01% | 2123 |
|
|
2016
Q1 | $84K | Buy |
+30,529
| New | +$84K | ﹤0.01% | 1906 |
|